BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34635222)

  • 1. Chemometric analysis of the global pattern of volatile organic compounds in the exhaled breath of patients with COVID-19, post-COVID and healthy subjects. Proof of concept for post-COVID assessment.
    Zamora-Mendoza BN; Díaz de León-Martínez L; Rodríguez-Aguilar M; Mizaikoff B; Flores-Ramírez R
    Talanta; 2022 Jan; 236():122832. PubMed ID: 34635222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of profiles of volatile organic compounds in exhaled breath by means of an electronic nose as a proposal for a screening method for breast cancer: a case-control study.
    Díaz de León-Martínez L; Rodríguez-Aguilar M; Gorocica-Rosete P; Domínguez-Reyes CA; Martínez-Bustos V; Tenorio-Torres JA; Ornelas-Rebolledo O; Cruz-Ramos JA; Balderas-Segura B; Flores-Ramírez R
    J Breath Res; 2020 Sep; 14(4):046009. PubMed ID: 32698165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of global chemical patterns in exhaled breath for the discrimination of lung damage in postCOVID patients using olfactory technology.
    Zamora-Mendoza BN; Sandoval-Flores H; Rodríguez-Aguilar M; Jiménez-González C; Alcántara-Quintana LE; Berumen-Rodríguez AA; Flores-Ramírez R
    Talanta; 2023 May; 256():124299. PubMed ID: 36696734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of volatile organic compounds in the urine of patients with cervical cancer. Test concept for timely screening.
    Díaz de León-Martínez L; Flores-Ramírez R; López-Mendoza CM; Rodríguez-Aguilar M; Metha G; Zúñiga-Martínez L; Ornelas-Rebolledo O; Alcántara-Quintana LE
    Clin Chim Acta; 2021 Nov; 522():132-140. PubMed ID: 34418363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of breath-prints for the COPD detection associated with smoking and household air pollution by electronic nose.
    Rodríguez-Aguilar M; Díaz de León-Martínez L; Gorocica-Rosete P; Padilla RP; Thirión-Romero I; Ornelas-Rebolledo O; Flores-Ramírez R
    Respir Med; 2020 Mar; 163():105901. PubMed ID: 32125969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of chemoresistive gas sensors and chemometric analysis to differentiate the fingerprints of global volatile organic compounds from diseases. Preliminary results of COPD, lung cancer and breast cancer.
    Rodríguez-Aguilar M; Díaz de León-Martínez L; Gorocica-Rosete P; Pérez-Padilla R; Domínguez-Reyes CA; Tenorio-Torres JA; Ornelas-Rebolledo O; Mehta G; Zamora-Mendoza BN; Flores-Ramírez R
    Clin Chim Acta; 2021 Jul; 518():83-92. PubMed ID: 33766555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
    Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
    Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a characteristic VOCs pattern in the exhaled breath of post-COVID subjects: are metabolic alterations induced by the infection still detectable?
    Di Gilio A; Palmisani J; Picciariello A; Zambonin C; Aresta A; De Vietro N; Franchini SA; Ventrella G; Nisi MR; Licen S; Barbieri P; Altomare DF; de Gennaro G
    J Breath Res; 2023 Jul; 17(4):. PubMed ID: 37379826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of chemical breath-prints through olfactory technology for the discrimination between SARS-CoV-2 infected patients and controls.
    Rodríguez-Aguilar M; Díaz de León-Martínez L; Zamora-Mendoza BN; Comas-García A; Guerra Palomares SE; García-Sepúlveda CA; Alcántara-Quintana LE; Díaz-Barriga F; Flores-Ramírez R
    Clin Chim Acta; 2021 Aug; 519():126-132. PubMed ID: 33901429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose.
    Kunos L; Bikov A; Lazar Z; Korosi BZ; Benedek P; Losonczy G; Horvath I
    Sleep Breath; 2015 Mar; 19(1):247-53. PubMed ID: 24840212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-COVID syndrome screening through breath analysis using electronic nose technology.
    V R N; Mohapatra AK; V K U; Lukose J; Kartha VB; Chidangil S
    Anal Bioanal Chem; 2022 May; 414(12):3617-3624. PubMed ID: 35303135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Term Effect of Cigarette Smoke on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose.
    Dragonieri S; Quaranta VN; Buonamico E; Battisti C; Ranieri T; Carratu P; Carpagnano GE
    Biosensors (Basel); 2022 Jul; 12(7):. PubMed ID: 35884323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of an e-nose performance for the detection of COVID-19 specific biomarkers.
    Ghazaly C; Biletska K; Thevenot EA; Devillier P; Naline E; Grassin-Delyle S; Scorsone E
    J Breath Res; 2023 Feb; 17(2):. PubMed ID: 36749983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    Biomarkers; 2019 Feb; 24(1):70-75. PubMed ID: 30074408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    J Bras Pneumol; 2016 Apr; 42(2):143-5. PubMed ID: 27167436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breath Prints for Diagnosing Asthma in Children.
    Sas V; Cherecheș-Panța P; Borcau D; Schnell CN; Ichim EG; Iacob D; Coblișan AP; Drugan T; Man SC
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Asthma Phenotype Discrimination Using an Electronic Nose Breath Analyzer.
    Plaza V; Crespo A; Giner J; Merino JL; Ramos-Barbón D; Mateus EF; Torrego A; Cosio BG; Agustí A; Sibila O
    J Investig Allergol Clin Immunol; 2015; 25(6):431-7. PubMed ID: 26817140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.